<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In 160 patients with <z:e sem="disease" ids="C0006111" disease_type="Disease or Syndrome" abbrv="">disorders of brain</z:e> circulation in cerebral <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, 68 <z:mpath ids='MPATH_458'>normals</z:mpath> and 38 patients with different <z:e sem="disease" ids="C0027765" disease_type="Disease or Syndrome" abbrv="">neurological diseases</z:e> (a control group), a special study was undertaken to study the antibrain antibodies with the aid of a complement fixation test (CFT), and a test of complement utilization (CUT) </plain></SENT>
<SENT sid="1" pm="."><plain>Positive results in the CFT and CUT were seen in patients with <z:hpo ids='HP_0002140'>ischemic strokes</z:hpo> and transient <z:e sem="disease" ids="C0006111" disease_type="Disease or Syndrome" abbrv="">disorders of brain</z:e> circulation </plain></SENT>
<SENT sid="2" pm="."><plain>The formation of antibodies to brain tissues depends upon their type, duration of the disease and is more characteristic of the rehabilitation period </plain></SENT>
<SENT sid="3" pm="."><plain>In studying autoimmune processes in patients with disordered brain circulation previous diseases should be taken into consideration (brain trauma, <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e>, <z:hpo ids='HP_0001297'>strokes</z:hpo>) </plain></SENT>
<SENT sid="4" pm="."><plain>The existence of antibrain antibodies correlates with the intensity of the process </plain></SENT>
</text></document>